Virtual Pathology Symposium

Saturday, February 5, 2022 7:00 AM to 4:00 PM

Overview

To keep practicing pathologists, hematologists and oncologists abreast of Precision Medicine in Hematopathology, the University of Arizona College of Medicine – Phoenix Department of Pathology has invited experts from the University of Chicago, the University of Pennsylvania, Emory University and the college to share their knowledge and experiences on the practice of Precision Hematopathology. Some practicing guidelines will be discussed by the expert speakers, and these guidelines will be updated annually via this symposium. To ensure the maximum participation by practicing pathologists, hematologists/oncologists and residents, this symposium will be held virtually on Saturday, February 5, 2022.

Objectives

  1. Select which patients will benefit from targeted therapy.
  2. Utilize optimal molecular testing protocols to identify therapeutic targets.
  3. Ensure patients optimized and personalized for targeted therapy.
  4. Ensure physicians to be familiar with precision hematopathology practice.

Schedule

Session One

7:00 a.m. – Welcome and Introduction of Speakers

Xianfeng Frank Zhao, MD, PhD, MBA
Frank Zhao, MD, PhD, MBA
Professor and Chair, Department of Pathology, UArizona College of Medicine – Phoenix

7:10 a.m. – Keynote: NPM-ALK: The Prime Example of Potent Oncogene and Therapeutic Target

Mariusz Wasik, MD
Mariusz Wasik, MD
Professor and Chair, Department of Pathology, D&S Morel and S&S Bayster Endowed Chair, Associate Director, Fox Chase Cancer Center

8:10 a.m. – Precision Hematopathology in Myelodysplastic Syndrome and Related Disorders

George Deeb, MD
George Deeb, MD
Associate Professor, Department of Pathology and Laboratory Medicine, Emory University

8:45 a.m. – Break

 

8:50 a.m. – Precision Medicine in Acute Myeloid Leukemia

Shiyong Li, MD, PhD
Shiyong Li, MD, PhD
Professor and Head of Hematopathology, Department of Pathology and Laboratory Medicine, Emory University

9:25 a.m. – A New Journey to Genomics and Precision Medicine

Xia Li, PhD
Xia Li, PhD
Associate Professor, Department of Pathology, UArizona College of Medicine – Phoenix

10:00 a.m. – Utility of Chromosomal Microarray in the Evaluation of Suspected Pediatric Hematolymphoid Malignancies

Kristian Schafernak, MD
Kristian Schafernak, MD
Associate Professor, Department of Pathology, UArizona College of Medicine – Phoenix

10:35 a.m. – Break

 


Session Two

11:25 a.m. – Introduction of Speakers

Shiyong Li, MD, PhD
Shiyong Li, MD, PhD

11:30 a.m. – Keynote: Molecular Implications in Precision Therapy of Myeloid Neoplasms

Dan Arber, MD
Dan Arber, MD
Chair, Department of Pathology, Donald West and Mary Elizabeth King Professor of Pathology, University of Chicago

12:30 p.m. – Molecular Applications in CLL: From Diagnosis to Detection of Measurable Residual Disease

Deniz Peker Barclift, MD
Deniz Peker Barclift, MD
Associate Professor, Department of Pathology and Laboratory Medicine, Emory University

1:05 p.m. – Break

 

1:10 p.m. – Precision Pathology of Diffuse Large B-Cell Lymphoma

Xianfeng Frank Zhao, MD, PhD, MBA
Frank Zhao, MD, PhD, MBA

1:45 p.m. – Histiocytic Neoplasm: An Update in the Era of Personalized Genomic Medicine

Saja Asakrah, MD, PhD
Saja Asakrah, MD, PhD
Assistant Professor, Department of Pathology and Laboratory Medicine, Emory University

2:20 p.m. – Advancement of Decision Support with Pharmacogenomics and Informatics

Hamed Abbaszadegan, MD, MBA
Hamed Abbaszadegan, MD, MBA
Associate Professor, Departments of Pathology and Biomedical Informatics, UArizona College of Medicine – Phoenix

2:55 p.m. – Closing Remarks

Shiyong Li, MD, PhD
Shiyong Li, MD, PhD


Contact

For questions, please contact either Dr. Frank Zhao or Sonia Vega.

Exhibitors/Sponsors

Caris Logo

Labcorp Logo

Accreditation Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The University of Arizona College of Medicine – Tucson and the UArizona College of Medicine – Phoenix. The University of Arizona College of Medicine – Tucson is accredited by the ACCME to provide continuing medical education for physicians.

The University of Arizona College of Medicine – Tucson designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.